Vol. 281, Issue 2, H882-H887, August 2001
31P NMR quantitation of phosphorus metabolites in
rat heart and skeletal muscle in vivo
Sam
Hitchins,
Julie M.
Cieslar, and
Geoffrey P.
Dobson
Department of Physiology and Pharmacology, School of Biomolecular
and Molecular Sciences, James Cook University, Townsville QLD 4811, Australia
 |
ABSTRACT |
The aim of this study was to
examine two methods of 31P NMR quantitation of
phosphocreatine (PCr), ATP, and Pi in rat heart and
skeletal muscle in vivo. The first method employed an external standard
of phenylphosphonic acid (PPA; 10 mM), and the second method used an
enzymatic measurement of tissue ATP equated to the area under the
ATP peak. With the use of the external standard, the concentrations
of ATP, PCr, and Pi in the rat heart were 4.48 ± 0.33, 9.21 ± 0.65, and 2.25 ± 0.16 µmol/g wet wt,
respectively. With the use of the internal ATP standard, measured on
the same tissue, the contents (means ± SE) were 4.78 ± 0.19, 9.83 ± 0.18, and 2.51 ± 0.33 µmol/g wet wt,
respectively (n = 7). In skeletal muscle, ATP, PCr, and
Pi were 6.09 ± 0.19, 23.44 ± 0.88, and
1.81 ± 0.18 µmol/g wet wt using the PPA standard and 6.03 ± 0.19, 23.30 ± 1.30, and 1.82 ± 0.19 µmol/g wet wt
using the internal ATP standard (n = 6). There was no
significant difference for each metabolite as measured by the two
methods of quantification in heart or skeletal muscle. The results
validate the use of an external reference positioned symmetrically
above the coil and imply that each has similar NMR sensitivities
(similar signal amplitude per mole of 31P between PPA and
tissue phosphorus compounds). We conclude that PCr, ATP, and
Pi are nearly 100% visible in the normoxic heart and
nonworking skeletal muscle given the errors of measurement.
heart; ATP; ADP; Pi
 |
INTRODUCTION |
APPLICATION OF
31p nmr spectroscopy has gained increasing popularity
in recent years in providing a window into metabolism and cellular
bioenergetics, but a number of concerns remain (2, 6, 14, 19,
20). Notwithstanding the problem of NMR sensitivity (>0.5 mM),
a longstanding difficulty has been how to convert the number of
"spins" into an absolute tissue concentration (12). Two popular methods for quantifying the absolute phosphorus
concentration in tissues are using an external reference standard
(9, 28) and using tissue ATP measured independently after
the experiment and equating the content to the area under the
ATP
peak (8, 13, 14, 20, 29). Other methods of quantitation
include internal [1H]H2O calibration
(27) and the use of a synthesized NMR reference produced
by the transmittance of signal from an electronic device received at
the same time as the sample signal (2). The assumptions of
all these methods are not trivial and involve knowledge of the
radiofrequency and coil loading properties, inhomogeneity in the
B1 coil, volume sensitivities, the effect of motion, and the choice of spectral analysis program (28, 29).
Using differences between an external standard and measured ATP has led
some investigators to propose an up to 40% invisibility of ATP in the
heart (26, 30). Invisibility is a complex term but largely
reflects line broadening from the highly decreased mobility of a
phosphorus compound, e.g., from compartmentation. One of the greater
difficulties, however, with invoking invisibility is that one has to be
confident that all the technical assumptions mentioned above are not a
contributing factor. The aim of this study is to take these factors
into account and compare the two most common methods of an external
standard and comparing the phosphorus concentrations with freeze-clamp
ATP values measured from the same tissues in rat heart and
gastrocnemius muscle in vivo. Our study showed that by
positioning the external standard above the coil and providing
symmetrical volume sensitivities, both methods agreed to within
5-10% at 7 T. The heart showed the greatest discrepancy due to
the lower signal-to-noise ratio, primarily from motion effects.
 |
EXPERIMENTAL PROCEDURES |
Surgical Protocol
Heart.
Seven male Sprague-Dawley rats weighing 300-350 g were obtained
from the James Cook University (JCU) breeding colony and housed in the
animal facility. Rats were supplied with unrestricted access to food
and water. Animals were anesthetized with an intraperitoneal injection
of pentobarbital sodium (60 mg/kg rat weight). The left femoral artery
and vein were cannulated with polyethylene (PE)-50 tubing. The venous
line was used for maintenance of anesthesia (15 mg/ml solution of
pentobarbital sodium in 0.9% saline), whereas the arterial line was
used for blood collection and continuous monitoring of blood pressure.
The arterial line was flushed periodically with a 100 U/ml solution of
heparin in 0.9% saline (David Bull Laboratories; Melbourne,
Australia). Blood pressure was measured using a pressure transducer
interfaced to a Maclab 200 (AD Instruments; Castle Hill, Australia) and
Apple Macintosh computer.
After cannulation, animals were artificially ventilated on room air
with a Harvard Small Animal Ventilator (Harvard Apparatus; South
Natick, MA) to give a blood PO2 of ~90 mmHg,
a PCO2 of ~40 mmHg, and a pH of ~7.4. Blood
(0.2 ml) was drawn from the arterial line and analyzed with the
Ciba-Corning 865 blood gas analyzer (Ciba Corning Diagnostic; Medfield,
MA) to ensure that blood gases were within the correct range.
A thoracotomy was performed, and a custom-built flexible arm surface
coil (9-mm outer diameter) tunable to 31P was placed on the
left ventricle. The coil was made of Teflon-coated copper wire (1.25 mm
thick) and was sufficiently flexible to follow the movement of the
heart and maintain contact without excessive pressure against the
heart. A thin-walled latex balloon containing 10 mM phenylphosphonic
acid (PPA) in D2O (Aldrich Chemical; Milwaukee, WI) was
placed on top of the surface coil. The configuration of coil, heart,
and standard is illustrated in Fig. 1. No
significant alteration in blood pressure or heart rate was seen on
placement of the coil.

View larger version (34K):
[in this window]
[in a new window]
|
Fig. 1.
Configuration of the surface coil assembly in the heart
(skeletal muscle not shown). The diagram is a cross-sectional view
showing the symmetrical arrangement of the balloon standard [10 mM
phenylphosphonic acid (PPA)] above a three-turn surface coil, with the
apical region of the left ventricular wall positioned below the coil.
|
|
The sampling depth of the surface coil was determined on a multilayer
phantom. Four plastic disks enclosed on both sides by a thin
latex membrane were assembled and filled with 100 mM
Na2HPO4, phosphocreatine (PCr), PPA, and
glucose-6-phosphate standards, respectively. The disks were then
layered to form four successive layers, each 2 mm thick (Fig.
2). A fully relaxed 31P
spectrum was obtained using the same surface coil described above to
determine the relative signal contribution from each layer.

View larger version (21K):
[in this window]
[in a new window]
|
Fig. 2.
31P NMR signal arising from consecutive 2-mm
layers of a multilayered phantom (inset) using the
three-turn surface coils used for the rat heart (solid bars) and rat
skeletal muscle (open bars). The signal from each layer is presented as
a percentage of the total signal from all four layers.
|
|
Skeletal muscle.
Six male Sprague-Dawley rats weighing 350-400 g were obtained from
the Animal Resources Centre (Canning Vale, Australia) and housed in the
animal facility at JCU. Rats were supplied with unrestricted access to
food and water. Animals were anesthetized with an intraperitoneal
injection of pentobarbital sodium (60 mg/kg rat weight),
tracheotomized, and ventilated using a Harvard Small Animal Ventilator
to give a blood PO2 of ~90 mmHg, a
PCO2 of ~40 mmHg, and a pH of ~7.4. Blood
gases were analyzed with the Ciba-Corning 865 blood gas analyzer.
Anesthesia was maintained by delivering 1% isoflurane (Abbott
Australasia; Kurnell, Australia) in compressed air via the ventilator
at a rate of 0.5 l/min. The right carotid artery was cannulated with
PE-50 tubing and utilized for blood collection and continuous
monitoring of blood pressure. The arterial line was flushed
periodically with a 100 U/ml solution of heparin in 0.9% saline. Blood
pressure was measured using a Statham P23 XL pressure transducer
interfaced to a Maclab 200 and Apple Macintosh computer.
The animal was transferred to a custom-built Perspex cradle.
The cradle was prefitted with a 37°C water-heated pad. The
gastrocnemius was exposed, and the muscle was carefully denuded of
overlying tissue and covered with a plastic film to prevent drying of
exposed tissue. A three-turn surface coil (14-mm outer diameter)
tunable to 31P was placed on the center of the
gastrocnemius muscle. A thin-walled latex balloon containing 10 mM PPA
was placed on top of the surface coil. The sampling depth of the
surface coil was determined in the same manner as described for the heart.
NMR Spectroscopy
Heart.
31P NMR experiments were performed at 121.47 MHz in a
110-mm horizontal bore Oxford 7.05-T superconducting magnet. The magnet is the property of the School of Molecular and Biomedical Sciences (JCU). 31P spectra were obtained using a Varian Inova NMR
spectrometer. Magnetic field homogeneity was maximized on the
1H free induction decay (FID) measured off resonance using
an Oxford Instruments 15-channel shim supply. Radiofrequency pulses of
8-µs duration at an ~40° flip angle were applied with a 1-s
interpulse delay. FIDs were acquired over 0.4 s with a total of
1,024 FIDs averaged. An spectral width of 8,000 Hz was used, and 6,400 data points were obtained. An exponential line broadening factor of 10 Hz was applied to the 31P NMR spectra, which were then
fitted using the Varian Fitspec software. After integration, all peaks
were multiplied by a saturation correction factor specific for each
peak. These factors were determined experimentally by comparing the
peak integrals of partially relaxed spectra, obtained using the
acquisition parameters described above, to the peak integrals of fully
relaxed spectra (20-s interpulse delay). Mean values were used in NMR
calculations of individual phosphorus compounds in the heart (and
skeletal muscle) for a 1-s acquisition delay.
In the heart, the mean correction factors for the 10 mM PPA external
standard, Pi, PCr, and
ATP were 1.12 ± 0.03, 0.97 ± 0.08, 1.24 ± 0.04, and 0.87 ± 0.03 (± SE,
n = 7), respectively. On completion of spectral
acquisition, the heart was freeze-clamped in vivo at the temperature of
liquid nitrogen. Tissue was ground to a powder in liquid nitrogen and
stored at
80°C for later enzymatic analysis of tissue ATP
concentration (described below).
Skeletal muscle.
31P NMR experiments in muscle were performed using the same
instrumentation as for the heart experiments. Radiofrequency pulses of
8-µs duration at an ~90° flip angle were applied with a 1-s interpulse delay. FIDs were acquired over 0.8 s with a total of 256 FIDs averaged. A spectral width of 6,000 Hz was used, and 9,600 data points were obtained.
Spectral intensities of phosphorus compounds were determined by
computer integration using the Varian (VNMRX) software. Opposed to
heart spectra, a line-fitting program was not required for muscle
because of the superior signal-to-noise ratio. The partially relaxed
31P spectra were calibrated by comparison with fully
relaxed spectra using the same process described for the heart (see
above). In muscle, the mean correction factors for the 10 mM PPA
external standard, Pi, PCr, and
ATP were 1.29 ± 0.08, 0.98 ± 0.10, 1.03 ± 0.01, and 0.88 ± 0.09 (±SE, n = 6), respectively. On completion of spectral
acquisition, the muscle was freeze-clamped in vivo, and the tissue was
powdered in liquid nitrogen for enzymatic determination of ATP concentration.
Metabolic Analysis
All chemicals used in the metabolic assays were purchased from
either Sigma or Boehringer-Mannheim and were of the highest grade.
Frozen powdered heart or muscle tissue (100 mg) was weighed at the
temperature of liquid nitrogen in a plastic Eppendorf tube containing
200 mg of 0.5-mm diameter glass beads. Ice-cold 3.6% perchloric acid
(PCA; 800 µl) was added to the tissue, and the resultant mixture was
homogenized for 1 min with a Mini-bead-beater (Biospec Products;
Bartlesville, OK). After the homogenate was centrifuged at 9,000 g for 10 min at 4°C, 600 µl of the resulting supernatant
were neutralized to pH 6-8 with 3.0 M KHCO3. The
extract was spun again for 10 min at 9,000 g at 4°C, and
the supernatant was stored at
80°C. ATP was measured in PCA
extracts with a spectrophotometer (GBC; Dandenong, Australia) using the
enzymatic method of Lowry and Passonneau (21).
Phosphorus Quantification
Two independent methods of peak standardization were utilized to
determine the concentration of Pi, PCr, and ATP. First, the
ATP peak was used as an internal standard. In this method, the enzymatically determined ATP concentration in freeze-clamped tissues was equated with the integral of the
ATP peak. The
saturation-corrected phosphorus metabolite integrals were then
standardized from the saturation-corrected
ATP peak as follows
|
(1)
|
|
(2)
|
|
(3)
|
where SCF is the saturation correction factor for each
metabolite in heart and skeletal muscle (see above).
The second method employed PPA as an external standard. Notwithstanding
issues of signal-to-noise ratios and peak integration methods, the
following equations (Eq. 4-10) present the theory of
using an external reference positioned symmetrically above the coil and
heart tissue as follows.
The observed signal (S) (or integral of the phosphorus metabolite in
heart) is given by
|
(4)
|
where
is the spin density distribution of the source signal,
V is volume where signal is measured and B1 coil is the
sensitivity of the coil system, which is generally the
transverse field at a point in space normalized to the amplitude per
mole of phosphorus metabolite. For the reference signal,
= [PPA] × fPPA (x, y, z), where fPPA (x,
y, z) is the spatial distribution. If we
take f = 1 inside the sphere containing the standard
PPA and f = 0 outside, therefore
|
(5)
|
The tissue phosphorus signal (e.g., PCr) from Eq. 4
above will therefore be
|
(6)
|
which leads to
|
(7)
|
and assumes that PCr is uniformly distributed. If
f = 1 inside the heart and f = 0 outside, as for PPA in the sphere (Eq. 5), the volume
integral is limited to the convoluted volume of the heart. Therefore,
given these conditions
|
(8)
|
From these equations, PPA can be used as the external standard
(Eq. 5) to determine tissue PCr (Eq. 8). The two
basic assumptions of the method are that 1) [PCr] is
uniformly distributed in the heart, and 2) the sensitivity
of the coil system yields identical signal amplitude per mole of
31P between PPA and phosphorus compounds in the heart.
Therefore
|
(9)
|
If these assumptions are correct, then
|
(10)
|
The concentration of PCr then becomes the equivalent of
micromoles of metabolite per gram wet weight in equal volumes (taking into account that 1 ml of water is equivalent to 1 g, and 1 ml tissue is equivalent to 1.1 g).
The saturation-corrected phosphorus metabolite integrals were
standardized from the saturation-corrected 10 mM PPA integral as
follows
|
(11)
|
|
(12)
|
|
(13)
|
Intracellular pH
Intracellular pH (pHi) was calculated from the
chemical shift [
, in parts per million (ppm)] of Pi
relative to PCr in the 31P spectra using the NMR version of
the Henderson-Hasselbalch equation (1)
|
(14)
|
Free Magnesium
Intracellular free Mg2+ concentration
([Mg2+]i) was calculated from the observed
chemical shift difference (

; in ppm) between
P
and
P resonances of ATP in the 31P spectra using a
modified form of the London equation (11)
|
(15)
|
where
= [H+]/KH and
=
(KD/K'D).
KH is the dissociation constant for the
H+/ATP4
equilibrium,
KD is the dissociation contant for the
ATP4
/Mg2+ equilibrium, and
K'D is the dissociation
constant for the ATPH3
/Mg2+
equilibrium. The parameters
1,
2,
3, and
4 were assigned published values
of 10.600, 11.660, 8.165, and 8.52 ppm, respectively; KD was 9.0 × 10
5 M,
KH was 3.4 × 10
7 M, and
K'D was 7.2 × 10
4M
(11).
Statistical Analysis
All values are means ± SE. Student's t-tests
were applied for statistical comparisons, with the
-level of
significance set at P < 0.05. P values are
also reported for comparisons between the two methods of quantification.
 |
RESULTS |
The sampling depths of the surface coils used for in vivo
determination of phosphorus metabolite concentrations in heart and skeletal muscle are shown in Fig. 2. In the heart, ~70% of the signal came from the first 2 mm of tissue below the coil and ~90% came from within the first 4 mm. With the larger coil for skeletal muscle, 50% came from the first 2 mm and a total of 85% came from the
first 6 mm below the coil. The thickness of the ventricle wall directly
beneath the coil was measured in our study and found to be ~4 mm in
thickness and 8 mm in rat gastrocnemius muscle below the site of coil
placement. Given these distances, we conclude that over 90% of
signal was received from both ventricular and skeletal muscle.
Table 1 summarizes the data
obtained from the two methods of quantitation of ATP, PCr, and
Pi in heart and skeletal muscle in vivo. With the use of
the external standard (10 mM PPA), the mean concentrations of ATP, PCr,
and Pi in the heart were 4.48, 9.21, and 2.25 µmol/g wet
wt, respectively. With the use of the internal ATP standard measured
enzymatically on the same tissue, the mean contents were 4.78, 9.83, and 2.51 µmol/g wet wt, respectively. There were no significant
differences for each metabolite and the two methods of quantification
in the heart. The P values for ATP, PCr, and Pi
for the two methods are 0.41, 0.34, and 0.46, respectively (Table
1).
View this table:
[in this window]
[in a new window]
|
Table 1.
31P NMR-determined ATP, PCr, and Pi in rat
heart and gastrocnemius muscle in vivo derived from an external PPA
standard and an internal ATP standard measured enzymatically on
tissue extracts from the same hearts
|
|
For skeletal muscle, using the external standard, the concentrations of
ATP, PCr, and Pi were 6.09, 23.44, and 1.81 µmol/g wet
wt, and, for the internal standard, the concentrations were 6.03, 23.30, and 1.82 µmol/g wet wt, respectively. In skeletal muscle, as
in the heart, no significant differences were found between the two
methods and each phosphorus compound. The P values for ATP,
PCr, and Pi for the two methods are 0.83, 0.93, and 0.97, respectively (Table 1). Free [Mg2+]i was
assessed by the relative chemical shift of the
ATP to
ATP peaks
in 31P NMR spectra and found to be 0.46 ± 0.04 mM
(average chemical shift of 8.64 ± 0.03) in heart and 0.57 ± 0.04 mM (average chemical shift of 8.58 ± 0.01) in skeletal
muscle. pHi, determined from the chemical shift between
Pi and PCr, was 7.32 ± 0.04 (average chemical shift
of 5.17 ± 0.04) in heart and 7.18 ± 0.02 (average chemical
shift of 5.03 ± 0.02) in skeletal muscle.
 |
DISCUSSION |
Our study shows that 31P NMR determination of absolute
concentrations of ATP, PCr, and Pi in heart and skeletal
muscle can be accurately measured using either external references or
an internal ATP standard. No significant differences were found between
the two methods in determining each phosphorus compound in heart or skeletal muscle. The higher P values in skeletal muscle
demonstrate a tighter agreement (100-101% difference in means of
metabolite concentrations between the two methods) compared with heart
(89-94%).
External and Internal Standardization of NMR Spectra
The major assumptions of the external PPA method are outlined in
EXPERIMENTAL PROCEDURES. The method is only valid to the extent that the sensitivity profile and homogeneity of the PPA reference is identical (or similar) to heart tissue. The excellent agreement between the two methods suggests that both of these assumptions were adequately satisfied. The major advantage of the
external PPA method is that continuous spectra can be acquired over the
time course of the experiment and precludes use of more invasive
techniques to estimate internal concentrations of ATP.
On the other hand, the major advantage of the internal ATP enzymatic
method is that the molar sensitivities and coil-sensitive volumes are
identical. However, two potential sources of error require comment.
First, it is known that a small fraction of the total tissue ATP
resides in the mitochondria (~5 and 10% in muscle and the heart,
respectively), and this would lead to higher levels of ATP, PCr, and
Pi than reported in Table 1. Second, the internal method
assumes that 100% of enzymatically measured ATP is equal to the total
nucleoside triphosphate (NTP) pool under the
ATP peak. We
(8) have shown previously that ATP represents ~93% of
the total NTP (ATP + UTP + CTP + ITP + GTP) in the
rat heart. The net effect of underestimation of ATP from mitochondrial
sequestration and overestimation from using the total NTP area appears
to be of similar magnitude in opposing directions. Therefore, we
conclude that equating tissue measurements of ATP with the area under
the
ATP peak is valid for heart and skeletal muscle given the
excellent agreement between both methods.
Differences Between Heart and Skeletal Muscle
The lower P values found in heart compared with
skeletal muscle (Table 1) may relate to the assumption that the
phosphorus compounds are not homogenous in the myocardium (see
EXPERIMENTAL PROCEDURES). The ventricular chamber is one
obvious difference between heart and skeletal muscle, which may have
led to the lower ATP and PCr measurements found in the heart but not in
skeletal muscle using the PPA method. A second reason for the
lower P values in the heart may be lower signal-to-noise
ratios from movement itself; the rat heart beats at 350 beats/min.
Another small but significant factor in the heart may also be
contaminating phosphorus compounds from ventricular blood. The
possibility is supported in part by the high Pi value
(2.25 ± 0.16 µmol/g wet wt from the external standard) compared
with literature values of ~1 mM (18). The higher values
in our study are probably due to high concentration of
2,3-diphosphoglycerate (~4 mM) in rat blood (3).
With the use of a heart wall thickness of 4 mm and the data in Fig. 2, a chamber blood contamination of ~10% would not be out of the question. With a 10% chamber blood space and a 10% tissue whole blood
space (8), the Pi would decrease by ~50%,
to a value of ~1.3 µmol/g. The Pi in rat gastrocnemius
skeletal muscle (1.81 µmol/g wet wt or 2.85 mM intracellular water;
Table 1) agrees well with the NMR published values of 1.9 µmol/g wet
wt of Madhu et al. (22), 2.7 mM of Shoubridge et al.
(25), and 4.9 mM of Mizuno et al. (24).
NMR Visibility of ATP
Over the past few decades, there has been much controversy as to
whether ATP is 100% 31P NMR visible in the heart. Within
the errors of the methods, we conclude that ATP is entirely visible in
both normoxic rat heart and skeletal muscle. "Invisibility" is a
complex term and generally refers to extreme line broadening due to the
relative immobility of phosphorus nuclei from macromolecular binding,
containment of nuclei within highly viscous compartments, or
association with paramagnetic ions (16).
Our data agree with most other findings in the perfused rat heart
(1, 7, 10, 13, 30) but are in contrast to those studies
that have identified an invisible fraction of ATP ranging from 30 to
40% of total ATP (26, 30). Differences of this magnitude
are difficult to reconcile given all the checks and balances required
to quantify the concentrations as outlined earlier. ATP invisibility in
the heart, but not skeletal muscle (4, 23), may also
relate to differences in lower signal-to-noise ratios and incomplete
myocardial occupancy of the coil sensitive volume through cardiac
motion and/or chamber contamination. As discussed, these factors can
introduce errors that significantly underestimate the ATP concentration.
While our study indicates that there is little or no NMR invisiblity of
ATP in rat heart and skeletal muscle, it does not exclude the
possibility of intracellular compartmentalization within the NMR
"visible" volume. The possibility of microcompartmentation has been
explored within the context of high-energy phosphate shuttling between
the sites of ATP production and utilization (15, 17).
In conclusion, the present study demonstrates the use of a symmetrical
external standard configuration positioned above the coil, which can
provide accurate concentrations of ATP, PCr, and Pi in both
heart and skeletal muscle in vivo. The method is valid to the extent
that the sensitivity profile and homogeneity of the reference is
identical (or similar) to the tissue. Our estimates of ATP, PCr, and
Pi were not significantly different from the internal
method of employing ATP measured on tissue extracts prepared from the
same tissue. The main disadvantage of using enzymatic ATP as an
internal standard is that larger numbers of animals are required at
different times during an experiment compared with the external method.
Our study further concludes that PCr, ATP, and Pi are
nearly 100% visible in the normoxic heart and nonworking skeletal
muscle given the errors of measurement.
 |
ACKNOWLEDGEMENTS |
This study was supported by National Heart Foundation Grant G00B
0547 (to G. P. Dobson).
 |
FOOTNOTES |
Address for reprint requests and other correspondence: G. P. Dobson, Dept. of Physiology and Pharmacology, School of Biomolecular and Molecular Sciences, James Cook Univ., Townsville QLD 4811, Australia (E-mail: geoffrey.dobson{at}jcu.edu.au).
The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement"
in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
Received 13 November 2000; accepted in final form 29 March 2001.
 |
REFERENCES |
1.
Bak, MI,
and
Ingwall JS.
NMR invisible ATP in heart: fact or fiction?
Am J Physiol Endocrinol Metab
262:
E943-E947,
1992[Abstract/Free Full Text].
2.
Barantin, L,
Pape AL,
and
Akoka S.
A new method for absolute quantitation of MRS metabolites.
Magn Reson Med
38:
179-182,
1997[Web of Science][Medline].
3.
Cieslar, J,
Huang MT,
and
Dobson GP.
Tissue spaces in rat heart, liver, and skeletal muscle in vivo.
Am J Physiol Regulatory Integrative Comp Physiol
275:
R1530-R1536,
1998[Abstract/Free Full Text].
4.
Dawson, MJ,
Gadian DG,
and
Wilkie DR.
Mechanical relaxation rate and metabolism studied in fatiguing muscle by phosphorus nuclear magnetic resonance.
J Physiol (Lond)
299:
465-84,
1980[Abstract/Free Full Text].
5.
Dobson, GP,
and
Cieslar JH.
Intracellular, interstitial and plasma spaces in the rat myocardium in vivo.
J Mol Cell Cardiol
29:
3357-3363,
1997[Web of Science][Medline].
6.
Dobson, GP,
and
Headrick JP.
Bioenergetic scaling: metabolic design and body size constraints in mammals.
Proc Natl Acad Sci USA
92:
7317-7321,
1995[Abstract/Free Full Text].
7.
Dobson, GP,
Veech RL,
Hoeger U,
and
Passonneau JV.
Enzymatic determination of total CO2 in freeze-clamped animal tissues and plasma.
Anal Biochem
195:
232-237,
1991[Web of Science][Medline].
8.
Dobson, GP,
Veech RL,
Passonneau JV,
Kobayashi K,
Inubushi T,
Wehrli S,
Nioka S,
and
Chance B.
31P NMR and enzymatic analysis of cytosolic phoshocreatine, ATP, Pi and intracellular pH in the isolated working perfused rat heart.
NMR Biomed
5:
20-28,
1992[Web of Science][Medline].
9.
Gard, JK,
and
Ackerman JJH
An external reference for intact biological systems.
J Magn Reson
51:
124-127,
1983.
10.
Garlick, PB,
and
Townsend RM.
NMR visibility of Pi in the perfused rat hearts is affected by changes in substrate and contracility.
Am J Physiol Heart Circ Physiol
263:
H497-H502,
1992[Abstract/Free Full Text].
11.
Golding, EM,
and
Golding RM.
Interpretation of 31P MRS spectra in determining intracellular free magnesium and potassium ion concentrations.
Magn Reson Med
33:
467-474,
1995[Web of Science][Medline].
12.
Hajek, M.
Quantitative NMR spectroscopy: comments on methodology of in vivo MR spectroscopy in medicine.
Qt Magn Reson Biol Med
2:
165-193,
1995.
13.
Humphrey, SM,
and
Garlick PB.
NMR-visible ATP and Pi in normoxic and reperfused rat hearts: a quantitative study.
Am J Physiol Heart Circ Physiol
260:
H6-H12,
1991[Abstract/Free Full Text].
14.
Ingwall, JS.
Phosphorus nuclear magnetic resonance spectroscopy of cardiac and skeletal muscles.
Am J Physiol Heart Circ Physiol
242:
H729-H744,
1982.
15.
Jacobus, WE.
Theoretical support fo the heart phosphocreatine energy transport shuttle based on the intracellular diffusional limited mobility of ADP.
Biochem Biophys Res Commun
133:
1035-1041,
1985[Web of Science][Medline].
16.
Jeffrey, FM,
Storey CJ,
Nunnally RL,
and
Malloy CR.
Efffect of ischemia on NMR detection of phosphorylated metabolites in intact rat heart.
Biochemistry
28:
5323-5326,
1989[Medline].
17.
Kammermeier, H.
Why do cells need phosphocreatine and a phosphocreatine shuttle?
J Mol Cell Cardiol
19:
115-118,
1987[Web of Science][Medline].
18.
Katz, LA,
Swain JA,
Portman MA,
and
Balaban RS.
Intracellular pH and inorganic phosphate content of heart in vivo: a 31P NMR study.
Am J Physiol Heart Circ Physiol
255:
H189-H196,
1988[Abstract/Free Full Text].
19.
Kushmerick, M.
Integrated human muscle bioenergetic studies by magnetic resonance methods.
Int J Sports Med
18:
S304-S306,
1997.
20.
Kushmerick, MJ,
and
Meyer RA.
Chemical changes in rat leg muscle by phosphorus nuclear magnetic resonance.
Am J Physiol Cell Physiol
248:
C542-C549,
1985[Abstract/Free Full Text].
21.
Lowry, O,
and
Passonneau JV.
A Flexible System of Enzymatic Analysis. New York: Academic, 1972.
22.
Madhu, B,
Lagerwall K,
and
Soussi B.
Phosphorus metabolites in difference muscles of the rat leg by 31P image-slected in vivo spectroscopy.
NMR Biomed
9:
327-332,
1996[Web of Science][Medline].
23.
Meyer, RA,
Kushmerick MA,
and
Brown TR.
Application of 31P NMR spectroscopy to the study of striated muscle metabolism.
Am J Physiol Cell Physiol
242:
C1-C11,
1982[Abstract/Free Full Text].
24.
Mizuno, T,
Takanashi Y,
Yoshizaki K,
and
Kondo M.
Fatigue and recovery of phosphorus metabolites and pH during stimulation of rat skeletal muscle: an evoked electromyography and in vivo 31P-nuclear magnetic resonance spectroscopic study.
Eur J Physiol Physiol Occup Physiol
69:
102-109,
1994[Web of Science][Medline].
25.
Shoubridge, EA,
Bland JL,
and
Radda GK.
Regulation of creatine kinase during steady-state isometric twitch contraction in skeletal muscle.
Biochim Biophys Acta
805:
72-78,
1984[Medline].
26.
Takami, H,
Furuya E,
Tagawa K,
Seo Y,
Murakami M,
Watari H,
Matsuda H,
Hirose H,
and
Kawashima Y.
NMR-invisible ATP in rat heart and its change in ischemia.
J Biochem (Tokyo)
104:
35-39,
1988[Abstract/Free Full Text].
27.
Thulborn, KR,
and
Ackerman JJH
Absolute molar concentrations by NMR in inhomogeneous B1. A scheme for analysis of in vivo metabolites.
J Magn Reson
55:
357-371,
1983.
28.
Tofts, PS,
and
Wray S.
A critical assessment of methods of measuring metabolite concentrations by NMR spectroscopy.
NMR Biomed
1:
1-10,
1988[Medline].
29.
Van den Boogaart, A,
Howe FA,
Rodrigues LM,
Stubbs M,
and
Griffiths JR.
In vivo 31P MRS: absolute concentrations, signal-to-noise and prior knowledge.
NMR Biomed
8:
87-93,
1995[Web of Science][Medline].
30.
Williams, JP,
and
Headrick JP.
Differences in nucleotide compartmentation and energy state in isolated and in situ rat heart assessed by 31P-NMR spectroscopy.
Biochim Biophys Acta
1276:
71-79,
1996[Medline].
Am J Physiol Heart Circ Physiol 281(2):H882-H887
0363-6135/01 $5.00
Copyright © 2001 the American Physiological Society